Search Within

Pamela Munster

Formats
  1. Journal Article (18)
  2. Meeting Abstract (12)
Groups
  1. Breast Medicine Service (27)
  2. Department of Medicine (27)
  3. Solid Tumor Oncology Division (27)
  4. GSK Faculty (18)
  5. Molecular Pharmacology and Chemistry Program Faculty (18)
  6. Sloan Kettering Institute Faculty (18)

More Groups

People
  1. Neal Rosen (18)
  2. David Solit (9)
  3. Clifford Hudis (8)
  4. Andrea Basso (7)
  5. Fuzhong Zheng (7)
  6. Larry Norton (7)

More People

Years
  1. 2003 (1)
  2. 2002 (3)
  3. 2001 (12)
  4. 2000 (6)
  5. 1999 (8)
Publications
  1. Clinical Cancer Research (10)
  2. Cancer Research (3)
  3. Cancer Investigation (2)
  4. Journal of Clinical Oncology (2)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  6. Cell Biology International (1)

More Publications

Publishers
  1. American Association for Cancer Research (15)
  2. Elsevier Inc. (4)
  3. American Society of Clinical Oncology (2)
  4. Informa Healthcare (2)
  5. C M P Medica LLC * The Oncology Group (1)
  6. HMP Communications (1)

More Publishers

Results (30)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • New drugs in gynecologic cancer
    Journal Article

    Daud, A.; Munster, P.; Spriggs, D. R.
    Current Treatment Options in Oncology (2001)

    Fulltext@MSK | Save
  • Modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemotherapy-induced apoptosis in an RB- and schedule-dependent manner. See: The Biology Behind: E. A. Sausville, Combining cytotoxics and 17-allylamino, 17-demethoxygeldanamycin: Sequence and tumor biology matters. Clin. Cancer Res., 7: 2155-2158, 2001
    Journal Article

    Munster, P. N.; Basso, A.; Solit, D.; Norton, L.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells
    Journal Article

    Chiosis, G.; Timaul, M. N.; Lucas, B.; Munster, P. N.; Zheng, F. F.; Sepp-Lorenzino, L.; Rosen, N.
    Chemistry and Biology (2001)

    Fulltext@MSK | Save
  • The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells
    Journal Article

    Munster, P. N.; Troso-Sandoval, T.; Rosen, N.; Rifkind, R.; Marks, P. A.; Richon, V. M.
    Cancer Research (2001)

    Fulltext@MSK | Save
  • Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCl, in metastatic breast cancer
    Journal Article

    Mùˆnster, P. N.; Buzdar, A.; Dhingra, K.; Enas, N.; Ni, L.; Major, M.; Melemed, A.; Seidman, A.; Booser, D.; Theriault, R.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells
    Journal Article

    Mùˆnster, P. N.; Srethapakdi, M.; Moasser, M. M.; Rosen, N.
    Cancer Research (2001)

    Fulltext@MSK | Save
  • Development of targeted ansamycins as novel anti-steroid agents and tyrosine kinase inhibitors in the treatment of breast and prostate cancers
    Meeting Abstract

    Zheng, F. F.; Kuduk, S. D.; Munster, P. N.; Chiosis, G.; Sepp-Lorenzino, L.; Danishefsky, S. J.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) inhibits intracellular Akt kinase activity in HER2 overexpressing breast cancer cell lines and enhances the apoptosis induced by cytotoxic agents
    Meeting Abstract

    Munster, P. N.; Basso, A.; Solit, D.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • 17-allyl-amino-seldanamycin induces HER2 degradation and AKT inactivation in a human breast cancer xenograft model
    Meeting Abstract

    Solit, D.; Munster, P.; Basso, A.; Tong, W.; Agus, D.; Scher, H.; Norton, L.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Systemic 'adjuvant' chemotherapy of primary breast cancer
    Journal Article

    Munster, P.; Hudis, C.; Norton, L.
    Current Oncology (2000)

    Fulltext@MSK | Save